How to assess risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines

Infection Control and Hospital Epidemiology

Volumn 28, Issue 2, 2007, Pages 146-155

  Rutala, William A ^a,b   Weber, David J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; DISINFECTION; ENDOSCOPE; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION RISK; INSTRUMENT STERILIZATION; INTERPERSONAL COMMUNICATION; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; PRACTICE GUIDELINE; RISK ASSESSMENT; SURGICAL INSTRUMENT;

CROSS INFECTION; DISINFECTION; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES; RISK ASSESSMENT; STERILIZATION;

EID: 33847700197     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/511700     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. Ambulatory and inpatient procedures in the United States, 1996. Atlanta: Centers for Disease Control and Prevention; 1998:1-39.
2. Weber DJ, Rutala WA. Lessons from outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol 2001; 22:403-408.
3. Weber DJ, Rutala WA, DiMarino AJ Jr. The prevention of infection following gastrointestinal endoscopy: the importance of prophylaxis and reprocessing. In: DiMarino AJ Jr, Benjamin SB, eds. Gastrointestinal Diseases: An Endoscopic Approach. Thorofare, NJ: Slack, 2002:87-106.
4. Nelson DB. Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc 2003; 57:695-711.
5. Centers for Disease Control and Prevention. Bronchoscopy-related infections and pseudoinfections - New York, 1996 and 1998. MMWR Morb Mortal Wkly Rep 1999; 48:557-560.
6. Vanhems P, Gayet-Ageron A, Ponchon T, et al. Follow-up and management of patients exposed to a flawed automated endoscope washer-disinfector in a digestive diseases unit. Infect Control Hosp Epidemiol 2006; 27:89-92.
7. Roy KM, Ahmed S, Cameron SO, Shaw L, Yirrell D, Goldberg D. Patient notification exercise following a dentist's admission of the periodic use of unsterilized equipment. J Hosp Infect 2005; 60:163-168.
8. Carsauw H, Debacker N. Recall of patients after the use of an inactive lot of Cidex disinfection solution in Belgian hospitals. In: Program and abstracts of the 5th International Conference of the Hospital Infection Society, Edinburgh, Scotland, September 15-18, 2002. Abstract P7.16.
9. Srinivasan A, Wolfenden LL, Song X, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 2003; 348:221-227.
10. Kirschke DL, Jones TF, Craig AS, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med 2003; 348:214-220.
11. Amoore J, Ingram P. Learning from adverse incidents involving medical devices. Br Med J 2002; 325:272-275.
12. Spaulding EH. Chemical disinfection of medical and surgical materials. In: Lawrence C, Block SS, eds. Disinfection, Sterilization, and Preservation. Philadelphia: Lea & Febiger, 1968:517-531.
13. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, Sterilization, and Preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:881-917.
14. Simmons BP. CDC guidelines for the prevention and control of nosocomial infections. Guideline for hospital environmental control. Am J Infect Control 1983; 11:97-120.
15. Garner JS, Favero MS. CDC Guideline for handwashing and hospital environmental control, 1985. Infect Control 1986; 7:231-43.
16. Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1990; 18:99-117.
17. Rutala WA, 1994, 1995, and 1996 APIC Guidelines Committee. APIC guideline for selection and use of disinfectants. Association for Professionals in Infection Control and Epidemiology. Am J Infect Control 1996; 24:313-342.
18. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities: recommendations of CDC. MMWR In press.
19. Sehulster L, Chinn RYW, Healthcare Infection Control Practices Advisory Committee. Guidelines for environmental infection control in healthcare facilities. MMWR Morb Mortal Wkly Rep 2003; 52:1-44.
20. Weber DJ, Rutala WA. Environmental issues and nosocomial infections. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. Baltimore: Williams and Wilkins, 1997:491-514.
21. Schembre DB. Infectious complications associated with gastrointestinal endoscopy. Gastrointest Endosc Clin N Am 2000; 10:215-232.
22. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993; 118:117-128.
23. Nelson DB, Jarvis WR, Rutala WA, et al. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Infect Control Hosp Epidemiol 2003; 24:532-537.
24. Jackson FW, Ball MD. Correction of deficiencies in flexible fiberoptic sigmoidoscope cleaning and disinfection technique in family practice and internal medicine offices. Arch Fam Med 1997; 6:578-582.
25. Orsi GB, Filocamo A, Di Stefano L, Tittobello A. Italian national survey of digestive endoscopy disinfection procedures. Endoscopy 1997; 29:732-738.
26. Honeybourne D, Neumann CS. An audit of bronchoscopy practice in the United Kingdom: a survey of adherence to national guidelines. Thorax 1997; 52:709-713.
27. Cetse JC, Vanhems P. Outbreak of infection associated with bronchoscopes. N Engl J Med 2003;348:2039-2040.
28. Gerding DN, Peterson LR, Vennes JA. Cleaning and disinfection of fiberoptic endoscopes: evaluation of glutaraldehyde exposure time and forced-air drying. Gastroenterology 1982; 83:613-8.
29. Food and Drug Administration, Centers for Disease Control and Prevention. FDA and CDC public health advisory: infections from endoscopes inadequately reprocessed by an automated endoscope reprocessing system. Rockville, MD: Food and Drug Administration; 1999.
30. Favero MS. Sterility assurance: concepts for patient safety. In: Rutala WA, ed. Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare Facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology, 2001:110-119.
31. Duffy RE, Brown SE, Caldwell KL, et al. An epidemic of corneal destruction caused by plasma gas sterilization. Arch Ophthalmol 2000; 118:1167-1176.
32. Leape LL. Reporting of adverse events. N Engl J Med 2002; 347:1633-1638.
33. North Carolina General Statute §90-21.2.
34. Nystrom B. Disinfection of surgical instruments. J Hosp Infect 1981; 2:363-368.
35. Rutala WA, Gergen MF, Jones JF, Weber DJ. Levels of microbial contamination on surgical instruments. Am J Infect Control 1998; 26:143-145.
36. McQuillan GM, Kruszon-Moran D, Kottiri BJ, et al. Prevalence of HIV in the US household population: the national health and nutrition examination surveys, 1988 to 2002. J Acquir Immune Defic Syndr 2006; 41:651-656.
37. Ippolito G, Puro V, De Carli G, Italian Study Group on Occupational Risk of HIV Infection. The risk of occupational human immunodeficiency virus in health care workers. Arch Int Med 1993; 153:1451-1458.
38. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001; 50(RR-11):1-42.
39. Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255:1887-1891.
40. Zou S, Notari EP IV, Stramer SL, Wahab F, Musavi F, Dodd RY. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004; 44:1640-1647.
41. Heymann DL. Control of Communicable Diseases Manual. Washington DC: American Public Health Association, 2004.
42. McLaughlin RA, Genter MB, Cook MG, Zublena JP. Pollutants in ground water: risk assessment. Raleigh, NC: North Carolina Cooperative Extension Service; 1994. Available at: http://www.soil.ncsu.edu/publications/Soilfacts/AG- 439-08/AG-439-8.pdf. Accessed July 2006.
43. Van Aerts LAGJM, Kasper P, Queckenberg O, Mueller L, Cartwright A. International workshop on qualification and control of impurities. Drug Inf J 2006; 40:155-163.
44. Kroes R, Kleiner J, Renwick A. The threshold of lexicological concern concept in risk assessment. Toxicol Sci 2005; 86:226-230.
45. European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on the limits of genotoxic impurities, 2004. Available at: http://www.emea.eu.int/pdfs/human/swp/519902en.pdf. Accessed July 2006.
46. Department of Transportation. Most Americans live in elevated cancer risk areas, EPA study shows. Available at: http://knowledge.fhwa.dot.gov/cops/ italladdsup.nsf. Accessed June 2006.